News | January 26, 2022
Torrent Pharmaceuticals consolidated PAT at Rs 249 cr
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
_256_384.jpg)
The oversubscribed round was led by New York-based HOF Capital and welcomed new investors including Headline, East Ventures, MS&AD Ventures, DG Daiwa Ventures, Pioneer Fund, as well as existing investor Insignia Ventures Partners
_256_384.jpg)
Closing the Loop on single-use plastics
The covid health center will be managed and administered by the district administration of Ballari
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types
Avra Labs is a Hyderabad based contract manufacturing and research services (CRAMs) and specialty active pharmaceutical ingredients (API) manufacturer with four facilities across the states of Telangana and Andhra Pradesh
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
First of its kind integrated Heart Health Programme on its Health Station ‘hPod’
This agreement allows Natco to expand access to Covid-19 medicines in 105 countries in generic name
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
